ABBV vs ISPC · P/E 81, rev $61.16B vs rev $9.3M
AbbVie Inc (ABBV) versus iSpecimen Inc (ISPC) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. ISPC currently screens at market cap $4.4M.
Not investment advice. Open the ABBV and ISPC stock pages for the full models.
Not investment advice.